Mergers & Acquisitions

Robert Coury returns to Mylan as executive chairman amid the COVID-19 outbreak, and activities needed to close the combination of Mylan and Upjohn.

Sanofi and GSK aim to complete the development required for availability of a COVID-19 vaccine by the second half of 2021.

Innovation co-president Marvin Richardson takes over as CEO on April 25, succeeding Mary Reno, and co-president Tom Boyer will become chief strategy officer.

Sandoz will continue to operate its oral solids and dermatology business as part of the Sandoz U.S. business.

As it moves into its second century in business, Upsher-Smith Labs is focusing on innovating and growing its product offerings while maintaining its high standards.

Jill Regan of LexisNexis Risk Solutions Health Care examines how retail pharmacy leaders continue to respond to market changes in the new decade.

Charlotte's Web is poised to corner nearly 35% of the food/drug/mass CBD market with the acquistion, valued at roughly $99 million in equity consideration.

McKesson is conducting a search for Bansi Nagji's successor, who is stepping down as executive vice president and chief strategy and business development officer, on March 31.